News Page
Published December 2, 2025
Inspire said its new sleep apnea device, Inspire V, was the future. Executives promised strong demand, smooth rollout, and a “simple” launch.
However, behind the scenes, providers were stuck with old inventory, key systems weren’t ready, and many clinics couldn’t even bill insurers. Demand was weak, and Inspire hadn’t finished basic training or setup.
Then on August 4, 2025, the truth came out. Inspire slashed its profit forecast by more than 80%, admitting its launch had collapsed. The stock plunged about 32% in a single day — wiping out more than a billion dollars in value.
Investors were stunned. Confidence gone. Now, more shareholders are joining the lawsuit.